Results 51 to 60 of about 1,876,891 (401)

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial

open access: yesEuropean Heart Journal, 2017
Aims We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD).
Javier Bermejo   +97 more
semanticscholar   +1 more source

Emerging hemodynamic signatures of the right heart (Third International Right Heart Failure Summit, part 2) [PDF]

open access: yes, 2015
Despite the importance of preserved right ventricular structure and function with respect to outcome across the spectrum of lung, cardiac, and pulmonary vascular diseases, only recently have organized efforts developed to consider the pulmonary vascular ...
Maron, Bradley A.
core   +1 more source

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: Lesson from left-sided heart failure [PDF]

open access: yes, 2019
Sympathetic nervous system hyperactivity has a well-recognized role in the pathophysiology of heart failure with reduced left ventricular ejection fraction.
Bonaduce, Domenico   +10 more
core   +1 more source

Pulmonary heart disease: The heart-lung interaction and its impact on patient phenotypes

open access: yesPulmonary Circulation, 2013
Pulmonary heart disease (PHD) refers to altered structure or function of the right ventricle occurring in association with abnormal respiratory function.
P. Forfia, A. Vaidya, S. Wiegers
semanticscholar   +1 more source

Assessment of pulmonary artery pressure by echocardiography—A comprehensive review [PDF]

open access: yes, 2016
Pulmonary hypertension is a pathological haemodynamic condition defined as an increase in mean pulmonary arterial pressure ≥ 25mmHg at rest, assessed using gold standard investigation by right heart catheterisation.
Abbas   +36 more
core   +2 more sources

THE HEART IN PULMONARY TUBERCULOSIS [PDF]

open access: yesSouthern Medical Journal, 1908
n ...
openaire   +2 more sources

Congenital Heart Disease and Pulmonary Hypertension [PDF]

open access: yesHeart Failure Clinics, 2012
Many patients with congenital heart disease and systemic-to-pulmonary shunts develop pulmonary arterial hypertension (PAH), particularly if the cardiac defect is left unrepaired. A persistent increase in pulmonary blood flow may lead to obstructive arteriopathy and increased pulmonary vascular resistance, a condition that can lead to reversal of shunt ...
Gupta, Vedant   +2 more
openaire   +3 more sources

Epoprostenol Therapy for Pulmonary Arterial Hypertension [PDF]

open access: yes, 2015
Pulmonary arterial hypertension (PAH) is characterized by elevation of pulmonary artery pressure caused by pulmonary vasoconstriction and vascular remodeling, which leads to right heart failure and death.
Akagi, Satoshi   +6 more
core   +1 more source

Pulmonary Hypertension Due to Left Heart Disease

open access: yesIndian Journal of Cardiovascular Disease in Women WINCARS, 2016
The most common cause of pulmonary hypertension is left heart disease, arising in response to increased left ventricular or left a trial filling pressures[1,2,3].
James Fang, B. Borlaug
semanticscholar   +1 more source

Circulating histones as clinical biomarkers in critically ill conditions

open access: yesFEBS Letters, EarlyView.
Circulating histones are emerging as promising biomarkers in critical illness due to their diagnostic, prognostic, and therapeutic potential. Detection methods such as ELISA and mass spectrometry provide reliable approaches for quantifying histone levels in plasma samples.
José Luis García‐Gimenez   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy